Research On The Illegal Behavior Of Accounting Information Disclosure Of Kangmei Pharmaceutical

By the end of 2019,the number of A-share listed companies is nearly 3700,which reflects the further expansion of China's stock market.However,it should be noted that the quality of some listed companies is worrying.In 2019,18 companies in the A-share market withdrew due to losses for three consecutive years,and 9 listed companies were suspended for falling to pass the examination.2019 is the year with the most delisting and suspension of listed companies.On the one hand,it shows that the audit and supervision of the listed company are more strictly.On the other hand,it can also show that there are many problems in listed companies.Many listed companies are faced with unrestrained diversification,profit decline,stock price fluctuation and financing difficulties,listed companies want to take a share of high-profit industries,such as the real estate industry.As a result,there are problems in the company's business strategy.They don't focus on the main business.The business area is too large.The improvement of the company's internal governance can not keep up with the expansion of the company's scale.While the profit level drops,the demand for capital increases.In order to transmit the good signal of the enterprise's operation to the market and obtain more financing channels,listed companies will take risks to disclose false accounting information.This paper takes Kangmei pharmaceutical industry as a case study,and combines with fraud triangle theory,stakeholder theory,signaling theory and other related theories,and uses financial data and charts to review and analyze its false disclosure of accounting information from 2016 to 2018,analyzes the specific means and methods of false information disclosure,the negative impact on the enterprise itself,external investors and accounting firms,as well as the motivation and reasons of false information disclosure.The motives mainly include the transfer of interests of major shareholders,optimization of operating indicators,manipulation of stock prices and cover up the plight of the decline of performance of the Chinese medicine sector.The reasons are mainly from the point of view that the defect of the external functional mechanism provides the opportunity and possibility for Kangmei to cheat,which is also in line with the "opportunity" factor of the fraud triangle theory.Finally,according to the defect of the functional mechanism,the corresponding improvement measures are put forward,which can be from improving the internal governance mechanism,increasing the cost of illegal punishment for listed companies and strengthening the audit institutions and recommendation institutions to improve the quality of accounting information disclosure of Kangmei pharmaceutical industry.Improving the quality of accounting information disclosure of listed companies is very important for the development of enterprises and the healthy operation of the securities market.High quality accounting information disclosure can reduce the information asymmetry,unblock the communication channels between investors and listed companies,and protect the interests of small and medium-sized shareholders and other stakeholders.